At risk for syphilis or chlamydia? There’s a PEP for that
Doxycycline may be the next frontier for queer men and trans women at high risk for certain STIs.
March 19 2024 12:04 PM
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Doxycycline may be the next frontier for queer men and trans women at high risk for certain STIs.
Recent research finds that periodic fasting-like diets can reduce a person's risk of disease and biological age.
Many scientists are undeterred in the effort to prevent HIV without a lifetime of medication.
A study in HIV-positive humanized mice was 60 percent effective as opposed to the 29 percent efficacy in previous studies.
A new study delves into how stem cell transplantation can kill the virus behind AIDS.
Young people are driving the reduction.
Researchers will study benefits and cognitive decline among people living with HIv.
Students in Philadelphia proved anybody has what it takes to be a scientist,
Smoking is particularly dangerous for people living with HIV.
The drug clears toxic brain proteins and had positive results in mice.
Kundai Chinyenze leads a global initiative that refuses to stop until a vaccine is found.
The plant-based compound could be a potential HIV treatment used in combination with ART.
A new study indicates that some children with HIV were found to have lower auditory responses than those without.
The Phase 1 trial shows the new method could be a very viable option for preventing HIV transmission.
A new study shows hope for the 10 percent of HIV-positive patients who cannot rely on initial treatment meds.
A study involving macaques showed the injectable implant as fully effective at preventing HIV.
The first Phase 3 trial for a potential HIV vaccine has ended in disappointment.
Nearly 30 percent of HIV-positive people develop the lung disease in their lifetime.
The vaccine uses an engineered protein from within the virus.
A new effort will help elderly people with HIV live healthier lives less impacted by chronic illness.